Post-Therapy Pathologic Stage and Survival in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemoradiation

Post-Therapy Pathologic Stage and Survival in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemoradiation

BACKGROUND: Neoadjuvant chemoradiation before surgery is an emerging treatment modality for pancreatic ductal adenocarcinoma (PDAC). However, analysis of prognostic factors is limited for patients with PDAC treated with neoadjuvant chemoradiation and pancreaticoduodenectomy (PD). METHODS: The study...

Full description

Saved in:
Bibliographic Details
Main Author: Estrella, Jeannelyn (author)
Other Authors: Rashid, Asif (author), Fleming, Jason (author), Katz, Matthew (author), Lee, Jeffrey (author), Wolff, Robert (author), Varadhachary, Gauri (author), Pisters, Peter (author), Abdalla, Eddie (author), Vauthey, Jean-Nicolas (author), Wang, Hua (author), Gomez, Henry (author), Evans, Douglas (author), Abbruzzese, James (author), Wang, Huamin (author)
Format: article
Published: 2011
Online Access:http://hdl.handle.net/10725/2646
http://dx.doi.org/10.1002/cncr.26243
http://onlinelibrary.wiley.com/doi/10.1002/cncr.26243/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://hdl.handle.net/10725/2646
http://dx.doi.org/10.1002/cncr.26243
http://onlinelibrary.wiley.com/doi/10.1002/cncr.26243/full

Similar Items